Bull Hedging
  • Politics
  • Stocks
  • Business
  • Investing
  • Politics
  • Stocks
  • Business
  • Investing

Bull Hedging

Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin July 28, 2025
July 28, 2025
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

previous post
Maiden Drill Program Commences at Oasis Uranium Project
next post
America must win the AI race — and prepare for the worst

Related Posts

Pinnacle Provides Update on Proposed Acquisition of El...

January 30, 2025

Biotech and Pharma Market Update: Q3 2025 in...

October 27, 2025

Cartier Resources Inc. Announces AGM Election Results

May 28, 2025

Canada Makes Tech Leadership Moves: Axl Launches, Carney...

June 23, 2025

Asara Resources

July 8, 2025

Tech 5: CoreWeave Inks US$11.9 Billion OpenAI Deal,...

March 16, 2025

Lahontan Acquires Strategic Claims South of The York...

August 20, 2025

Leadership Streamlining and Cost Reductions

June 11, 2025

Stellar AfricaGold Inc Intersects Multiple Wide High-Grade Gold...

October 3, 2025

Blue Sky Hosts Community and Stakeholder Water Sampling...

June 13, 2025

Recent Posts

  • The Real Drivers of This Market: AI, Semis & Robotics
  • S&P 500 Breaking Out Again: What This Means for Your Portfolio
  • Trump files ‘powerhouse’ appeal in ‘politically charged’ Manhattan district attorney case
  • Trump predicts ‘very happy’ outcome ahead of face-to-face with China’s Xi after tariff threats
  • House Democrats accuse Trump of trying to ‘steal’ $230M from taxpayers through DOJ

Recent Comments

No comments to show.

About Us

About Us

Design Magazine

Welcome to Design Magazine. Follow us for daily & updated design tips, guide and knowledge.

Stay Connect

Facebook Twitter Instagram Pinterest Youtube Email

Recent Posts

  • The Real Drivers of This Market: AI, Semis & Robotics

    October 29, 2025
  • S&P 500 Breaking Out Again: What This Means for Your Portfolio

    October 29, 2025
  • Trump files ‘powerhouse’ appeal in ‘politically charged’ Manhattan district attorney case

    October 29, 2025
  • Trump predicts ‘very happy’ outcome ahead of face-to-face with China’s Xi after tariff threats

    October 29, 2025
  • House Democrats accuse Trump of trying to ‘steal’ $230M from taxpayers through DOJ

    October 29, 2025
  • Schumer again blocks GOP bid to reopen government as air traffic controllers go unpaid

    October 29, 2025

Editors’ Picks

  • 1

    Small Caps are Set to Skyrocket in 2025—Here’s What You Need to Know

    December 12, 2024
  • 2

    Ad revenue should stabilize for media companies in 2025 — if they have sports

    December 31, 2024
  • 3

    Trump leaves China guessing what his next move is with unusual inauguration invitation

    December 15, 2024
  • 4

    Lead Price Forecast: Top Trends for Lead in 2025

    January 11, 2025
  • 5

    Zinc Stocks: 4 Biggest Canadian Companies in 2025

    January 15, 2025
  • 6

    Uranium Price Forecast: Top Trends That Will Affect Uranium in 2025

    December 19, 2024
  • 7

    Trudeau declares himself ‘proud feminist’ after lamenting Harris loss to Trump as setback for women

    December 13, 2024
Promotion Image

banner

Categories

  • Business (585)
  • Investing (2,296)
  • Politics (2,803)
  • Stocks (870)
  • About us
  • Contacts
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting

Disclaimer: bullhedging.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2025 bullhedging.com | All Rights Reserved